All In Biotech

Free tool

FAERS Monitor: Diltiazem Hydrochloride In 0.72% Sodium Chloride

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 218038 or its brand name (Diltiazem Hydrochloride In 0.72% Sodium Chloride, Diltiazem Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

11,574

Serious

9,725

84% of reports

Hospitalization

5,333

Death reported

2,765

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • dyspnoea1,345
  • pain1,211
  • fatigue1,162
  • fall1,056
  • arthralgia921
  • diarrhoea912
  • headache904
  • dizziness899
  • nausea871
  • pruritus870
  • pyrexia844
  • drug ineffective843
  • hypotension842
  • off label use811
  • hypersensitivity748

Reports by year received

View as table
YearReports
2004381
2005388
2006235
2007173
2008185
2009169
2010220
2011192
2012310
2013282
2014210
2015256
2016297
2017311
2018312
2019358
2020519
2021873
20221,421
20231,092
20241,322
20251,294
2026774

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,042,585 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
hypotensionSignal8427.77.24,892
hypersensitivitySignal7487.36.94,116
fallSignal1,0565.85.54,224
pyrexiaSignal8444.44.22,279
dyspnoeaSignal1,3454.34.13,522
pruritusSignal8704.13.92,087
arthralgiaSignal9214.03.82,134
painSignal1,2113.63.42,321
dizzinessSignal8993.33.11,454
fatigueSignal1,1622.72.61,303
headacheSignal9042.62.5932
diarrhoeaSignal9122.62.4899
nauseaSignal8712.01.9452
off label use8111.71.6234
drug ineffective8431.21.120

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.